Phase I study of atevirdine mesylate (U-87201E) monotherapy in HIV-1-infected patients.
暂无分享,去创建一个
L. Resnick | J. Timpone | J. Holden-Wiltse | M. Fischl | W. Powderly | L. Demeter | R. Reichman | M. Para | L. Wathen | P. Meehan | G. Morse | T. Nevin | D. Batts | J. Leedom | C. Greisberger | K. Wood